Technology Transfer spanning the complete production process
Enzychem shall produce 80 million doses in 2022
SEOUL, South Korea & AHMEDABAD, India & ENGLEWOOD CLIFFS, N.J.--(BUSINESS WIRE)-- Enzychem Lifesciences (KOSDAQ: 183490) and Cadila Healthcare Ltd, a part of the Zydus Group, today announced that they have entered a Manufacturing License and Technology Transfer Agreement for the world
